archive

Agenda

8:15-9:45AM Session

Stripe, Role for TAVR In Asymptomatic Severe or Moderate Aortic Stenosis Patients

Rodriguez, Clinical and Anatomic Considerations for Alternative Access TAVR

Southard, Lifetime Management of a Young Patient with Severe Aortic Stenosis

Wong, TAVR for Patients with Aortic Insufficiency - Why Is It Taking So Long?

10:00-11:30AM Session

Rogers, Device/technology Updates for LAAO 

Muhammad, Current FDA Approved and Upcoming Expanding Indications for LAAO. What Does the Data Show Us? 

Atsina, Techniques to Optimize Intraprocedural Imaging Guidance for LAAO. 

Aryana, Contemporary Post Deployment Pharmacologic Strategies (NOAC vs APT)

12:00-1:30PM Session

Nguyen, PFO Considerations in Evaluating Cryptogenic Stroke, the Neurologists Perspective

Kamath, PFO Closure in the Non-prototypical Patient

Aman, Optimizing ASD Closure Using 3D ICE

1:45-3:45PM Session

Kiaii, Minimally Invasive Surgical Mitral Repair – Who is an Ideal Candidate? 

Singh, MTEER – State of the State in 2024

Cadeiras, GDMT Implementation and the Role for MTEER in the Advanced 
Cardiomyopathy Patient

Rogers, Why is TMVR Taking So Long To Get To A Cath Lab Near You!! 

Huang, Clinical Need and the Data to Support TTEER Intervention

Pham, How Will I Decide Between TTEER vs TTVR? 

4:00-5:30PM Session

Lee, Life Before and After

Scholnick, Goals of the Referral Relationship. What Do We Still Need?

Dillon, Balancing Patient Care vs. Patient Throughout